Sentences with phrase «by pharmaceutical development»
A large majority of AAPS members employed outside of academia (68 percent) are involved with a variety of specialties, led by pharmaceutical development, biopharmaceutics / pharmacokinetics, and management / administration of research and development.
http://www.sciencemag.org/ Not exact matches
Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol.
From 2010 through the approvals of Kyprolis ® and Stivarga ® and its acquisition by Amgen in October 2013, he was Vice President, Corporate Development and Strategy at Onyx Pharmaceuticals (NASDAQ: ONXX), where he served as Head of Strategy and Strategic Asset Management, and Head of Transactions.
In 2008, workers at pharmaceutical giant Pfizer's New London and Groton (Connecticut) research and development campus raised the alarm: They were being replaced by Indian workers on H - 1B visas and forced to train their replacements.
However, the changing operating models of global CMOs does highlight that Australian industry must ensure competitiveness by offering commercial development services alongside the manufacture of complex pharmaceuticals.
The company had this to say about him, probably written by Frank G. Ryan, the president, writing in Modern Pharmacy but covered in the Journal of the South Carolina Medical Association: «Three or four years ago, in the gradual development of our scientific staff, we secured the services of Professor Wilbur L. Scoville, a pharmacist well known to the country and a man preeminent in the field of what has been termed pharmaceutical elegance.
He was formerly employed by H.J. Heinz as a food technologist responsible for product and process development, and has consulted for the food and pharmaceutical industries.
Please be advised that a public hearing will be held by Rensselaer County Industrial Development Agency on the 7th day of December, 2017 at 6:00 p.m. at East Greenbush Town Hall, 225 Columbia Turnpike in the Town of East Greenbush, Rensselaer County, New York in connection with a proposed project to be undertaken by Regeneron Pharmaceuticals, Inc..
Over the past year, Kaloyeros has been working with local officials, including those at the Buffalo Niagara Medical Campus, to develop plans announced by Cuomo in December to invest $ 50 million in state funds to build and equip a pharmaceutical drug research and development center at the downtown medical campus.
In medicine today, physician - scientists and basic scientists supplement support for their research by applying their expertise part time to develop and test commercial products.1 In my own field, vision science, university - based researchers obtain additional funding through clinical and electrophysiologic studies, pathology, imaging, biochemistry, and animal model development performed for pharmaceutical and instrument companies.
In addition to a socially responsible mission, other advantages of working in the biotechnology and pharmaceutical industry, as identified by survey takers, were: engaging work and being part of cutting - edge research and development; innovative, creative, and fast - paced work; and stability in difficult economic times, including generous salaries, benefits, and job security.
If confirmed by clinical research, the data points to the possibility that early pharmaceutical intervention could make a significant difference in the development of the disease.
Studying how genes affect different drugs manufactured by different companies gives Poirier greater influence on future drug development, he feels, which would not be possible if he was employed at any one pharmaceutical research lab.
Other analysts have also noted that while research and development spending by pharmaceutical companies has increased dramatically, the number of new drug approvals has remained flat.»
These include various investments in R&D, manufacturing, and process development by giant pharmaceutical companies such as Norvartis, Eli Lilly, GlaxoSmithKline, Baxter, and Merck Sharp & Dohme.
Now a $ 60 billion market for the biotechnology and pharmaceutical sectors, growth of the market has been hampered by high development costs of producing these in animal cell systems, which when factoring in a long period for manufacturing, R&D and clinical trials, may reach around $ 1 billion per each therapeutic candidate.
The test called SkimuneTM, which is trademarked and has a patent pending, has been successfully tested by a number of large pharmaceutical companies on drugs in development and provides a reliable result within two weeks.
With Helmsley funding, CCFA's research consortium is now looking to identify potential therapies for development by pharmaceutical companies while also conducting a rigorous investigation of the effect of diet on the microbiome and how that might allow patients to alter the course of their illness without taking medications.
Recent past honorees include Julian Adams of Infinity Pharmaceuticals, Alfred Goldberg of Harvard Medical School and Kenneth Anderson and Paul Richardson, both of Dana - Farber Cancer Institute, for the development of bortezomib, a drug that has altered the lives of hundreds of thousands of people with multiple myeloma; Alain Carpentier of Hôpital Européen Georges Pompidou in Paris and Robert S. Langer of MIT for innovations in bioengineering; and the work of Harald zur Hausen and Lutz Gissmann of the German Cancer Research Center on human papillomavirus (HPV) and cancer of the cervix, which was recognized by the WAFP prior to their receiving the Nobel Prize.
This method is used by 80 % of major pharmaceutical companies and has contributed to the development of several approved drugs.
The application of Dr. Snyder's techniques has enhanced the development of new agents in the pharmaceutical industry by enabling rapid screening of large numbers of candidate drugs.
The symposium we've convened addresses the ways Organs - on - Chips technology is being used for drug development by pharmaceutical companies and for precision medicine by clinicians.
We collaborate with academic and corporate research and development organizations to characterize conditions mediated by senescent cells, and to identify pharmaceutical candidates that may control or ameliorate such conditions and increase healthspan.
Dr. Robert Urban of Johnson & Johnson will address how Organ - Chips are being used by the pharmaceutical industry today and the potential the technology holds to change the drug development process and reduce the use of animals in research.
Additional inhibitors targeting this pathway are under development by multiple pharmaceutical companies for this genetic disease and other conditions, including diabetic macular edema.
He said that teams like his are stepping in to fill a void left by the major pharmaceutical companies, which have not invested in the development of new antibiotics for many years.
SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.
As Head of Project Leader Unit, Nicolas is in charge of the pharmaceutical development and subsequent production of vaccines - for use in clinical trials - directly funded by the European Vaccine Initiative (EVI), and European projects funded from other sources coordinated by EVI.
It's commonly used for environmental and health analyses, as well as by industry for pharmaceutical and petrochemical product development.
Dr. Harris started his career in biotechnology in 1981 as a group leader in Molecular Biology at Celltech Group and from 1989 to 1993 was Director of Biotechnology at Glaxo Group Research in the U.K.. From 1993 until 1999, Dr. Harris was Chief Scientific Officer and Vice President of Research and Development at Sequana Therapeutics Inc. in San Diego, which became Axys Pharmaceuticals, Inc. in 1998 and was subsequently acquired by Celera Genomics.
Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa.
New drugs under development by various pharmaceutical companies are designed specifically to interfere with the signals transmitted by these receptors.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
He has contributed many fresh, innovative ideas, guided by his previous experience in various industries, such as pharmaceuticals, gourmet coffee, cigars, and computer software development.
Mr. Damon's commitment to raise $ 1 million through that group and the OneXOne Foundation in the next year was one of a bundle of pledges aimed at water and sanitation from individuals, charities and companies totalling about $ 400 million (including a $ 200 million pledge by Napo Pharmaceuticals to «complete the clinical development of crofelemer, a drug that has potential to treat pediatric diarrhea, and provide it at cost to partner organizations for distribution in the areas with the highest mortality and morbidity associated with diarrheal diseases.»)
A potentially game - changing breakthrough in artificial photosynthesis has been achieved with the development of a system that can capture carbon dioxide emissions before they are vented into the atmosphere and then, powered by solar energy, convert that carbon dioxide into valuable chemical products, including biodegradable plastics, pharmaceutical drugs and even liquid fuels.
Counseled contractors with respect to performance of federal agency contracts and grant agreements for biomedical and pharmaceutical research and development activities, including those awarded by the National Institutes of Health and the Biomedical Advanced Research and Development Authoridevelopment activities, including those awarded by the National Institutes of Health and the Biomedical Advanced Research and Development AuthoriDevelopment Authority (BARDA).
At our nationwide defective drug practice, we aim to assist those adversely affected by dangerous medications such as Lipitor, and we continuously monitor developments taking place within the pharmaceutical industry to better understand products and protect our clients» interests.
In particular, Eli Lilly claimed that the development of the «promise doctrine» in Canadian patent law led to the invalidation of patents protecting its drugs atomoxetine (Strattera ®) and olanzapine (Zyprexa ®) by Canadian courts, and that this doctrine was radically new, arbitrary, and discriminatory against pharmaceutical companies.
We have been involved in the development of group litigation in the UK, as pharmaceutical and healthcare product liability cases are often, by their nature, repercussive.
Acting for the senior lender on an underwritten debt package to fund the secondary buy - out by GHO Capital of Quotient Clinical, a provider of outsourced drug development services to the global pharmaceutical industry
The census also tracked salaries by industry, with defence and pharmaceutical industry in - house counsel earning the highest base salaries and in - house counsel from the research and development, trade association, and educational services sectors making the least.
According to the Tufts Center for the Study of Drug Development, large pharmaceutical, biotechnology and contract research organisations (CROs) plan to increase staff for collection and analysis of real world data by 25 % between now and 2020; this clearly marks a significant trend.
Biotechnology companies tend to be smaller than pharmaceutical companies and more driven by research and development.
Pharmacy graduates are also employed by private sector organisations, e.g. pharmaceutical companies and food and drink companies, to work in areas such as research and development, quality assurance, marketing, sales and management.
Though often overshadowed by medical device and pharmaceutical sales, biotech reps appreciate the industry's focus on innovation and product development.
Currently, the top - paying industries for pharmacists are physicians» offices ($ 131,460 annual mean wage), followed by outpatient care centers ($ 130,790), scientific research and development services ($ 129,580), and pharmaceutical and medicine manufacturing ($ 125,220).
Experiential rotations, organization - sponsored education, a major project and oversight by highly qualified preceptors will serve the Pharmacy Resident in the development of knowledge, skills, and the attitude needed to provide high quality pharmaceutical care.
Summary of Qualifications * Specialty Pharmaceuticals promoting a vast array of product portfolios to diverse customer markets along with extensive specialty product launch experience in the Chicagoland area * Competitive sales drive with desire and commitment to excel by delivering value to customers through differentiating products and services for Business Development * Creative thinker who translates sales needs and obj...